What did we learn from epidemiological studies in high background radiation area in India

被引:8
|
作者
Jayalekshmi, P [1 ]
Gangadharan, P [1 ]
Binu, VS [1 ]
Nair, RRK [1 ]
Nair, MK [1 ]
Rajan, B [1 ]
Akiba, S [1 ]
机构
[1] Karunagappally Canc Registry, Kerala, India
关键词
natural radiation; cancer;
D O I
10.1016/j.ics.2004.11.192
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Cancer causing potential of chronic exposure to high natural radiation seen in ChavaraNeendakara coast of Karunagappally taluk in Kerala, India is studied by the Natural Background Radiation Cancer Registry, Kartmagappally since 1990. Population survey of 359,619 people recorded socio-demographic (SD) information and radiation levels measured inside (71,674) and outside (76,942) houses. Radiation level between and within the panchayats showed large variations. About 23,000 population were exposed to > 4 mSv. Cancer pattern and trends were examined in relation to radiation levels. During 1990-2000 lung cancer was the predominant cancer among males (age adjusted rates (AAR) - 18.2), followed by esophagus (AAR - 6.3). Among females, cancers of the breast (AAR - 14.3), cervix (AAR - 13.4) and thyroid (AAR - 4.3) were the major cancers. Only marginal differences in cancer incidence and its pattern were seen in different areas when broadly classified according to radiation level zones. Increase of incidence of lung cancer with radiation was seen among males but not in females. This needs in-depth studies. Role of confounding and competing risk factors need to be assessed with larger data sets. (c) 2004 Published by Elsevier B.V.
引用
收藏
页码:102 / 105
页数:4
相关论文
共 50 条
  • [31] What did we learn from the era of big data?
    Cao, Wenshu
    BRITISH JOURNAL OF GENERAL PRACTICE, 2023, 73 (726): : 10 - 11
  • [32] What Did We Learn From the ADAPT Trials? Reply
    Terrault, Norah A.
    Hassanein, Tarek I.
    GASTROENTEROLOGY, 2019, 156 (03) : 825 - 826
  • [33] WHAT DID WE LEARN FROM 60S
    不详
    FARM CHEMICALS AND CROPLIFE, 1970, 133 (01): : 15 - &
  • [34] What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?
    Dickstein, K
    AMERICAN HEART JOURNAL, 2003, 145 (05) : 754 - 757
  • [35] Tripartite efflux pumps of the RND superfamily: what did we learn from computational studies?
    Athar, Mohd
    Gervasoni, Silvia
    Catte, Andrea
    Basciu, Andrea
    Malloci, Giuliano
    Ruggerone, Paolo
    Vargiu, Attilio Vittorio
    MICROBIOLOGY-SGM, 2023, 169 (03):
  • [36] World Youth Day 2008: What did we gain? What did we learn?
    Mason, Michael
    AUSTRALASIAN CATHOLIC RECORD, 2010, 87 (03): : 334 - 348
  • [37] Radiation dose in the high background radiation area in Kerala, India
    Christa, E. P.
    Jojo, P. J.
    Vaidyan, V. K.
    Anilkumar, S.
    Eappen, K. P.
    RADIATION PROTECTION DOSIMETRY, 2012, 148 (04) : 482 - 486
  • [38] The Silzone dilemma - What did we learn?
    Bodnar, E
    JOURNAL OF HEART VALVE DISEASE, 2000, 9 (02): : 170 - 173
  • [39] SARS wars - What did we learn?
    Gutkin, C
    CANADIAN FAMILY PHYSICIAN, 2003, 49 : 939 - 939
  • [40] THALIDOMIDE RETROSPECTIVE - WHAT DID WE LEARN
    FRASER, FC
    TERATOLOGY, 1988, 38 (03) : 201 - 202